Treatment
Activated Charcoal clinical trials
We’re tracking 6 recruiting studies that include Activated Charcoal, each written for real people, not researchers, below.
Recruiting studies
- NCT05471479RecruitingPhase 4
Activated charcoal for recent poisoning in hospital patients
This pilot study tests giving activated charcoal soon after a poisoning to see if it helps remove certain swallowed toxins. It may be an option if you arrive at the hospital within 6 hours and charcoal is medically safe for you.
Québec, QuebecAges Any age - NCT06906874RecruitingPhase 2
Activated charcoal for kidney disease patients on dialysis
This trial tests if taking activated charcoal by mouth can help people with advanced kidney disease who are already on dialysis. It may improve how the body handles certain waste products and reduce the need for other medicines.
Al Mansurah, Please SelectAges 18 years+ - NCT07201311RecruitingPhase 2
Stomach decontamination for severe poisoning in the ICU
This trial tests whether giving activated charcoal plus emptying the stomach can help people who are on a breathing machine after severe poisoning. It may lower the amount of poison in the body and improve recovery.
ParisAges 18 years+ - NCT04819217Recruiting
Probiotics and a toxin binder to slow chronic kidney disease
This trial studies an oral product (a “uremic toxin” absorber) plus probiotics to help slow the progression of chronic kidney disease. It may help by lowering harmful gut-related substances that can build up when kidney function is reduced.
TaipeiAges 20 years+ - NCT04792320Recruiting
Probiotics and fiber for kidney disease with leg artery blockage
This study tests whether an oral absorbent plus probiotics can improve gut health and circulation in people who have chronic kidney disease and symptomatic peripheral artery disease (PAD). It will also track changes in blood markers and how well blood vessels function.
TaipeiAges 20 years+ - NCT04788914Recruiting
Test saliva or blood markers to track kidney and leg disease treatment
This study looks at a gene marker (“lncRNA,” a natural molecule in the body) to see how well an oral absorbent, with or without probiotics, is helping people with chronic kidney disease (CKD) who also have blocked leg arteries. It may help doctors better measure treatment impact and tailor care.
Taipei, TaiwanAges 20 years+
What Activated Charcoal is being studied for
Conditions with recruiting Activated Charcoal studies.
Common questions
- Are there clinical trials studying Activated Charcoal?
- Yes. Clin2 currently lists 6 recruiting studies that include Activated Charcoal, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Activated Charcoal trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Activated Charcoal an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Activated Charcoal or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.